Imfinzi (durvalumab) - AstraZeneca
Imjudo (tremelimumab-actl) - AstraZeneca
Yervoy (ipilimumab) - BMS
Tecentriq (atezolizumab) - Roche
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Bavencio (avelumab) - EMD Serono
Keytruda (pembrolizumab) - Merck (MSD)
http://www.ncbi.nlm.nih.gov/pubmed/42717304
 
Adam C Bledsoe; Joseph A Murray; Razan Aburumman; Rok Seon Choung; Saqr Alsakarneh
 
Sep 11, 2026
 
Prev Next